Early response to vunakizumab and its baseline predictors in patients with moderate-to-severe plaque psoriasis: a post hoc analysis of a phase-III trial
Background Exploring predictors of early response is meaningful to optimize treatment strategies of patients with psoriasis. However, predictors of early response to vunakizumab remain unidentified.Objective This study aimed to investigate the early response rates to vunakizumab and identify predict...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis Group
2025-12-01
|
| Sarja: | Journal of Dermatological Treatment |
| Aiheet: | |
| Linkit: | https://www.tandfonline.com/doi/10.1080/09546634.2025.2564810 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|